Selective toxicity towards myelodysplastic hematopoietic progenitors - another rationale for iron chelation in MDS.
E
E
Fibach
E A
EA
Rachmilewitz
D001565:Benzoates / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects*; D000077588:Deferasirox; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000473:pathology*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D014230:Triazoles / Q000494:pharmacology*
D001565:Benzoates; D017382:Reactive Oxygen Species; D014230:Triazoles; D000077588:Deferasirox